These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 10446997)
1. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997 [TBL] [Abstract][Full Text] [Related]
2. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors. Sui L; Tokuda M; Ohno M; Hatase O; Hando T Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035 [TBL] [Abstract][Full Text] [Related]
3. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors. Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414 [TBL] [Abstract][Full Text] [Related]
4. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018 [TBL] [Abstract][Full Text] [Related]
5. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of p27(Kip1) in human breast cancers. Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577 [TBL] [Abstract][Full Text] [Related]
7. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Guo Y; Sklar GN; Borkowski A; Kyprianou N Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624 [TBL] [Abstract][Full Text] [Related]
8. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239 [TBL] [Abstract][Full Text] [Related]
9. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis. Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240 [TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850 [TBL] [Abstract][Full Text] [Related]
11. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
12. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer. Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related]
14. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma. Barbareschi M Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889 [TBL] [Abstract][Full Text] [Related]
15. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245 [TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912 [TBL] [Abstract][Full Text] [Related]
17. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. Sgambato A; Migaldi M; Faraglia B; Garagnani L; Romano G; De Gaetani C; Ferrari P; Capelli G; Trentini GP; Cittadini A Cancer Res; 1999 Jul; 59(13):3245-50. PubMed ID: 10397272 [TBL] [Abstract][Full Text] [Related]
18. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491 [TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G; Hunter T; Ruoslahti E Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134 [TBL] [Abstract][Full Text] [Related]
20. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]